Literature DB >> 8243890

Vacuolar apical compartment (VAC) in breast carcinoma cell lines (MCF-7 and T47D): failure of the cell-cell regulated exocytosis mechanism of apical membrane.

D E Vega-Salas1, J A San Martino, P J Salas, A Baldi.   

Abstract

We have previously shown that an integral plasma membrane glycoprotein (AP2) is highly polarized to the apical domain in confluent Madin-Darby canine kidney (MDCK) epithelial cells. However, when the monolayers are prevented from forming intercellular contacts, approximately 60% of the AP2 cellular content is stored in the intracellular vacuolar apical compartment (VAC). In the current work we found that AP2 was present in the non-tumorigenic human mammary epithelial cell line MCF-10A, in the breast carcinoma cell lines MCF-7 and T47D, and in breast ductal carcinomas in vivo. By radioimmunoassay, an intracellular compartment of AP2 was identified in the mammary cell lines in culture. In MCF-10A, this compartment behaved as in MDCK cells; namely it was observed only when the cells cannot form cell-cell contacts. However, in the carcinoma cell lines MCF-7 and T47D, a significant AP2 intracellular compartment was observed also under conditions permissive for the formation of intercellular contacts. These results were confirmed by immunofluorescence and immunoelectron microscopy experiments that showed VACs in MCF-7 and T47D, even in cells with extensive intercellular contacts. In MCF-7 cells, the addition of serum caused a partial decrease of the AP2 intracellular compartment. The exocytosis of VACs occurred towards the center of multi-cellular groups, forming intercellular lumens, similar to those transiently observed in MDCK cells and to structures described by others during embryo development. Altogether, these results suggest that VAC exocytosis is controlled by cell-cell contact signalling, which may be defective in carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243890     DOI: 10.1111/j.1432-0436.1993.tb00716.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  7 in total

1.  Intracellular redirection of plasma membrane trafficking after loss of epithelial cell polarity.

Authors:  S H Low; M Miura; P A Roche; A C Valdez; K E Mostov; T Weimbs
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

2.  Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment.

Authors:  Andrei I Ivanov; Asma Nusrat; Charles A Parkos
Journal:  Mol Biol Cell       Date:  2003-10-03       Impact factor: 4.138

3.  Cell polarity development and protein trafficking in hepatocytes lacking E-cadherin/beta-catenin-based adherens junctions.

Authors:  Delphine Théard; Magdalena Steiner; Dharamdajal Kalicharan; Dick Hoekstra; Sven C D van Ijzendoorn
Journal:  Mol Biol Cell       Date:  2007-04-11       Impact factor: 4.138

4.  Myosin 5b loss of function leads to defects in polarized signaling: implication for microvillus inclusion disease pathogenesis and treatment.

Authors:  Dmitri Kravtsov; Anastasia Mashukova; Radia Forteza; Maria M Rodriguez; Nadia A Ameen; Pedro J Salas
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-25       Impact factor: 4.052

5.  Par1b promotes hepatic-type lumen polarity in Madin Darby canine kidney cells via myosin II- and E-cadherin-dependent signaling.

Authors:  David Cohen; Yuan Tian; Anne Müsch
Journal:  Mol Biol Cell       Date:  2007-04-04       Impact factor: 4.138

6.  Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane.

Authors:  Markus Utech; Andrei I Ivanov; Stanislav N Samarin; Matthias Bruewer; Jerrold R Turner; Randall J Mrsny; Charles A Parkos; Asma Nusrat
Journal:  Mol Biol Cell       Date:  2005-07-29       Impact factor: 4.138

7.  Towards understanding microvillus inclusion disease.

Authors:  Georg F Vogel; Michael W Hess; Kristian Pfaller; Lukas A Huber; Andreas R Janecke; Thomas Müller
Journal:  Mol Cell Pediatr       Date:  2016-01-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.